Norms for Clinical Use of CXM, a Real-Time Marker of Height Velocity

CONTEXT: Height velocity (HV) is difficult to assess because growth is very slow. The current practice of calculating it from measurements taken at several-month intervals is insufficient for managing children with growth disorders. We identified a bone growth by-product (collagen X biomarker, CXM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Coghlan, Ryan F, Olney, Robert C, Boston, Bruce A, Coleman, Daniel T, Johnstone, Brian, Horton, William A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765635/
https://www.ncbi.nlm.nih.gov/pubmed/33034649
http://dx.doi.org/10.1210/clinem/dgaa721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765635/
https://www.ncbi.nlm.nih.gov/pubmed/33034649
http://dx.doi.org/10.1210/clinem/dgaa721

Ejemplares similares